Medical Ikkou Group Co.,Ltd.

3353

JP3921040006

Drug Retailers

Delayed Japan Exchange Other stock markets 10:55:11 2025-12-11 pm EST			5-day change	1st Jan Change
2,622.00 ^JPY	-0.19%		-2.31%	+27.96%

Apr. 23	Medical Ikkou Group Co.,Ltd. cancelled the acquisition of Shizuoka Sawai Yakuhin K.K. from Shinichi Takeshita.	CI
Apr. 04	Medical Ikkou Group - To Cancel Own Shares Representing 7.37% Issued Shares	RE

Medical Ikkou Group Co.,Ltd. agreed to acquire Okinawa Amel Co., Ltd. from Seibu Sawai Yakuhin K.K.

Published on 07/30/2023

S&P Capital IQ

Medical Ikkou Group Co.,Ltd.

-0.19%

Medical Ikkou Group Co.,Ltd. (TSE:3353) agreed to acquire Okinawa Amel Co., Ltd. from Seibu Sawai Yakuhin K.K. on July 31, 2023. The deal is xpected to be completed on September 1, 2023.

Latest news about Medical Ikkou Group Co.,Ltd.

Apr. 23	Medical Ikkou Group Co.,Ltd. cancelled the acquisition of Shizuoka Sawai Yakuhin K.K. from Shinichi Takeshita.	CI
Apr. 04	Medical Ikkou Group - To Cancel Own Shares Representing 7.37% Issued Shares	RE
Dec. 19	Medical Ikkou Group Co.,Ltd. signed a letter of intent to acquire Shizuoka Sawai Yakuhin K.K. from Shinichi Takeshita.	CI
Nov. 20	Medical Ikkou Group Co.,Ltd. entered into memorandum of understanding to acquire Keiyo Sawai Pharmaceutical Co., Ltd. from Ogawa Tsuyoshi and others.	CI
23-07-30	Medical Ikkou Group Co.,Ltd. agreed to acquire Okinawa Amel Co., Ltd. from Seibu Sawai Yakuhin K.K.	CI
23-07-30	Medical Ikkou Group Co.,Ltd. entered into basic agreement to acquire 50% stake in Hakuai Nakai Ethical Pharmacy Co., Ltd. from Kanichi Eguchi.	CI
23-04-07	Medical Ikkou Group Co.,Ltd. Reports Earnings Results for the Full Year Ended February 28, 2023	CI
20-06-17	Tranche Update on Medical Ikkou Group Co.,Ltd.'s Equity Buyback Plan announced on June 17, 2020.	CI
20-06-17	Medical Ikkou Group Co.,Ltd.'s Equity Buyback announced on June 17, 2020 has expired with 30,900 shares for ¥271.92 million.	CI
20-06-17	An unknown buyer acquired an unknown stake in Qol Holdings Co., Ltd. from Medical Ikkou Group Co.,Ltd..	CI
20-06-17	Medical Ikkou Group Co.,Ltd. announces an Equity Buyback for 40,000 shares, representing 2.1% for ¥352 million.	CI
20-06-16	Medical Ikkou Group Co.,Ltd. authorizes a Buyback Plan.	CI
19-02-25	Medical Ikkou Co., Ltd. cancelled the acquisition of Efa Co., Ltd from Nakagawa Sangyo Co.,Ltd and Takashi Nakagawa.	CI
18-11-21	Tranche Update on Medical Ikkou Co., Ltd.'s Equity Buyback Plan announced on November 21, 2018.	CI
18-11-21	Medical Ikkou Co., Ltd.'s Equity Buyback announced on November 21, 2018 has expired with 9,900 shares for ¥80.69 million.	CI
18-11-21	Medical Ikkou Co., Ltd. announces an Equity Buyback for 15,000 shares, representing 0.78% for ¥122.25 million.	CI
18-11-20	Medical Ikkou Co., Ltd. authorizes a Buyback Plan.	CI
18-02-25	Medical Ikkou Co., Ltd. agreed to acquire Efa Co., Ltd from Nakagawa Sangyo Co.,Ltd and Takashi Nakagawa.	CI
17-03-27	Medical Ikkou Co., Ltd. cancelled the acquisition to acquire Taiho Yakuhin Co., Ltd. from Seiichi Asai.	CI
16-12-15	Air Water Inc. completed the acquisition of 50.1% stake in Kawamoto Corporation.	CI
16-11-09	Air Water Inc. made a bid to acquire 50.1% stake in Kawamoto Corporation for approximately ¥910 million.	CI
16-07-31	Medical Ikkou Co., Ltd. acquired Tsurukame Chozai Pharmacy, Ltd from Takako Muraoka and Michip Muraoka.	CI
16-03-27	Medical Ikkou Co., Ltd. agreed to acquire Taiho Yakuhin Co., Ltd. from Seiichi Asai.	CI
15-08-27	Medical Ikkou Co., Ltd. cancelled the acquisition of 18.3% stake in Kurata Hoken Jimusho YK rom Hideki Kurata.	CI
14-08-27	Medical Ikkou Co., Ltd. signed an agreement to acquire 18.3% stake in Kurata Hoken Jimusho YK rom Hideki Kurata.	CI

Chart Medical Ikkou Group Co.,Ltd.

Duration

Period

3353: Dynamic Chart

Medical Ikkou Group Co.,Ltd. is a Japan-based company mainly engaged in the operation of dispensing pharmacies that fill prescriptions for general patients based on the medical prescriptions issued by medical institutions. The Company operates in four business segments. The Dispensing Pharmacy segment is specialized in the sale of medical drugs based on medical prescriptions. The Healthcare segment is engaged in the operation of nursing care facilities, the leasing of medical facilities and others, as well as the medical care and nursing care related businesses. The Medicine Wholesale segment is engaged in the sale of pharmaceutical products to medical institutions and others. The Real Estate segment is engaged in the leasing of real estate properties.

Employees

1,547

Sector

Drug Retailers

Calendar

Jan. 08 - Q3 2025 Earnings Release

More about the company